We are glad to report that the inception of the Journal of Pharmacovigilance has been greeted with enthusiasm. We believe that open-access if the way of the future when it comes to scientific reports in general and Pharmacovigilance reports in particular. The Journal of Pharmacovigilance follows a rigorous peer review always resulting in a fair number of rejections, but no paper is rejected without explanation. It is part of our mission to have our peer reviewers and editors help you improve the quality of your report independent of your decision to resubmit here or elsewhere. Adrian Preda, Pharmacovigilance and Beyond.
Last date updated on March, 2021